Dr. Johannes Dreizler was awarded the 2026 Kurt Ruths Prize by TU Darmstadt. Endowed with €12,000, the prize recognizes outstanding scientific achievements by early-career researchers. Johannes Dreizler earned his PhD at the Department of Chemistry at TU Darmstadt in the research group of PROXIDRUGS project leader Prof. Felix Hausch. In his dissertation, he developed novel molecular glues for targeted cancer therapy. These compounds bring disease-relevant target proteins into close proximity...

From climate-neutral industry and new mobility solutions to global health research: Germany’s innovation clusters are developing the ideas that will shape our society tomorrow. At re:publica 2026, the cluster and campus initiatives of the Federal Ministry of Research, Technology and Space (BMFTR) will, for the first time, jointly showcase their success stories. The PROXIDRUGS Cluster, based at Goethe University Frankfurt, is developing innovative drugs that can selectively degrade...

PROXIDRUGS scientist Xinlai Cheng and Cluster Speaker Ivan Đikić from Goethe University Frankfurt have received one of the prizes of the Innovation Award of the German BioRegions 2026 for their project “SpliceTACs: First-in-class spliceosome-targeting degraders.” The project had previously been selected as one of six finalists in this year’s competition and was presented on April 21, 2026, during the German Biotechnology Days in Leipzig to a high-level audience of investors, company...